HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ryan Faucette Selected Research

SRK-181

5/2021Nonclinical Development of SRK-181: An Anti-Latent TGFβ1 Monoclonal Antibody for the Treatment of Locally Advanced or Metastatic Solid Tumors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ryan Faucette Research Topics

Disease

2Hereditary Angioedemas
01/2017 - 10/2014
1Cardiotoxicity
05/2021
1Neoplasms (Cancer)
05/2021
1Angioedema
01/2017
1Obesity
05/2007

Drug/Important Bio-Agent (IBA)

2Monoclonal AntibodiesIBA
05/2021 - 10/2014
2Plasma KallikreinIBA
01/2017 - 10/2014
2lanadelumabIBA
01/2017 - 10/2014
1SRK-181IBA
05/2021
1Transforming Growth Factors (Transforming Growth Factor)IBA
05/2021
1Protein Isoforms (Isoforms)IBA
05/2021
1BradykininIBA
01/2017
1Kallikreins (Kallikrein)IBA
01/2017
1High-Molecular-Weight Kininogen (Kininogen, High Molecular Weight)IBA
01/2017
1Biological ProductsIBA
10/2014
1p38 Mitogen-Activated Protein KinasesIBA
05/2007
1Fatty Acids (Saturated Fatty Acids)IBA
05/2007

Therapy/Procedure

1Immunotherapy
05/2021